Search research articles
Contact Us
Filters
Showing results (391-400 of 760) with videos related to
Page
of 76
Sort By:
The American Journal of Cardiology
|
February 17, 2017
Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor
Michael A Gaglia, Michael J Lipinski, Thibault Lhermusier, et al.
Revista Espanola De Cardiologia (English Ed.)
|
September 25, 2021
Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial
Fernando Alfonso, José M de la Torre Hernández, Borja Ibáñez, et al.
Journal of Thrombosis and Thrombolysis
|
August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
Francesco Franchi, David J Schneider, Jayne Prats, et al.
Journal of the American College of Cardiology
|
June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial
Matthew J Price, James S Walder, Brian A Baker, et al.
JACC. Cardiovascular Interventions
|
February 23, 2013
Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy
José Luis Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Circulation. Cardiovascular Interventions
|
September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial
Jean G Diodati, Jorge F Saucedo, John K French, et al.
The Journal of Invasive Cardiology
|
July 23, 2025
Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysis
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study
Matthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.
Journal of Clinical Medicine
|
November 11, 2022
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
Felice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.
Cardiovascular Radiation Medicine
|
August 24, 2004
Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!
Dominick J Angiolillo, Manel Sabaté, Pilar Jiménez-Quevedo, et al.
Page
of 76
Search research articles
Search
Showing results (391-400 of 760) with videos related to
Sort By:
Page
of 76
The American Journal of Cardiology
|
February 17, 2017
Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor
Michael A Gaglia, Michael J Lipinski, Thibault Lhermusier, et al.
Revista Espanola De Cardiologia (English Ed.)
|
September 25, 2021
Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial
Fernando Alfonso, José M de la Torre Hernández, Borja Ibáñez, et al.
Journal of Thrombosis and Thrombolysis
|
August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
Francesco Franchi, David J Schneider, Jayne Prats, et al.
Journal of the American College of Cardiology
|
June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial
Matthew J Price, James S Walder, Brian A Baker, et al.
JACC. Cardiovascular Interventions
|
February 23, 2013
Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy
José Luis Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Circulation. Cardiovascular Interventions
|
September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial
Jean G Diodati, Jorge F Saucedo, John K French, et al.
The Journal of Invasive Cardiology
|
July 23, 2025
Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysis
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study
Matthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.
Journal of Clinical Medicine
|
November 11, 2022
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
Felice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.
Cardiovascular Radiation Medicine
|
August 24, 2004
Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!
Dominick J Angiolillo, Manel Sabaté, Pilar Jiménez-Quevedo, et al.
Page
of 76